Surgalign Holdings, Inc.

Surgalign Holdings, Inc. is a medical technology company, which engages in designing, developing, and manufacturing biologic metal and synthetic implants. Its products portfolio include cervical fixation, The Streamline (TL) fixation, motion preservation, orthobiologics, cervical inter-body fusion, TL IBF, and SI joint fusion. It offers coflex interlaminar stabilization device, SImmetry sacroiliac joint fusion system, and Fortilink IBF system with TETRAfuse?3D technology. The company was founded on February 12, 1998 and is headquartered in Deerfield, IL.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

RTI Surgical - OEM Business designs, develops, manufactures and distributes biologic, metal and synthetic implants for a global customer base. Its implants are used in a variety of surgical procedures including orthopaedic, spine, sports medicine, general surgery and trauma.

DEERFIELD, Ill., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA) (“Surgalign”), a global medical technology company focused on elevating the standard of care by driving the evolution of digital health, today announced that it intends to offer and sell, subject to market and other conditions, shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase shares of common stock in an underwritten public offering. Surgalign expects to grant the underwriter a 30-day option to purchase additional shares of its common stock and/or warrants at the public offering price, less the underwriting discounts and commissions. All of the securities to be sold in the offering are to be offered by Surgalign.

Surgalign Holdings, Inc. Announces Proposed Public Offering

DEERFIELD, Ill., Jan. 13, 2022 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital health, today announced that the management team will participate in a fireside chat at the Sidoti Virtual Small Cap Conference on Thursday, January 20, 2022. The Company is scheduled to present at 11:30 a.m. Eastern Time the same day via webcast.

Surgalign Holdings, Inc. to Participate at the Sidoti Virtual Small Cap Conference

Artificial Intelligence Technology Will Enable Computers to Autonomously Identify and Segment Neural Structures in Medical Images and Provide Reference Information Regarding Pathological States Artificial Intelligence Technology Will Enable Computers to Autonomously Identify and Segment Neural Structures in Medical Images and Provide Reference Information Regarding Pathological States

Surgalign Holdings, Inc. Expands Digital Health Capabilities with Acquisition of a Significant Equity Interest in Inteneural Networks Inc.

Document Security Systems

GEE Group

Sesen Bio Inc.

SNDL Inc.

Waitr Holdings Inc

These penny stocks trading for under $1 per share all have strong chances of delivering stunning returns in the coming year. The post 6 of the Best Penny Stocks Under $1 to Buy Now for 2022 appeared first on InvestorPlace.

6 of the Best Penny Stocks Under $1 to Buy Now for 2022

An investment in the company at a share price of $0.75 may result in returns of ~275% to ~770% by end of FY 2023.

Surgalign Holdings - A Future Of Digital Surgery

DEERFIELD, Ill., Dec. 20, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that the management team will participate in the 2022 H.C. Wainwright Virtual BioConnect Conference taking place January 10-13, 2022.

Surgalign Holdings, Inc. to Present at the 2022 H.C. Wainwright Virtual BioConnect Conference

DEERFIELD, Ill., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (NASDAQ: SRGA), a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced that the management team will participate in a fireside chat at the Piper Sandler 33rd Annual Virtual Healthcare Conference.

Surgalign Holdings, Inc. to Participate at the Piper Sandler 33rd Annual Virtual Healthcare Conference

CymaBay Therapeutics

PaySign Inc

Senseonics Holdings

Electrameccanica

CohBar

The broader market looks expensive, but these penny stocks provide low-cost opportunities for considerable upside according to analysts. The post 7 Penny Stocks With the Potential to 10X in 2022 appeared first on InvestorPlace.

7 Penny Stocks With the Potential to 10X in 2022

Surgalign reported GAAP EPS of -$0.06 (versus -$0.36 in the prior-year quarter) and missed revenues by $2.65M for FY 2021 Q3. The company guided for lower FY 2021 revenues by $7M to $8M on the bottom/top range, for total revenues of $88M to $92M for the year.

Surgalign Holdings: The Saga Continues

Surgalign Holdings, Inc. (SRGA) CEO Terry Rich on Q3 2021 Results - Earnings Call Transcript

Surgalign (SRGA) delivered earnings and revenue surprises of -50.00% and -8.89%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Surgalign Holdings (SRGA) Reports Q3 Loss, Misses Revenue Estimates

DEERFIELD, Ill., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today reported operating results for the third quarter of 2021.

Surgalign Holdings, Inc. Announces Third Quarter 2021 Results

DEERFIELD, Ill., Nov. 03, 2021 (GLOBE NEWSWIRE) -- Surgalign Spine Technologies, (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care through the evolution of digital surgery, today announced it plans to release financial results from the third quarter 2021 after the close of trading on November 9, 2021.

Surgalign Holdings, Inc. Schedules Third Quarter 2021 Earnings Release for November 9, 2021

Surgalign (SRGA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Surgalign Holdings (SRGA) May Report Negative Earnings: Know the Trend Ahead of Q3 Release

Advaxis

These penny stocks are trading for under a dollar, but could change that in the coming months with their strong fundamentals. The post 6 of the Hottest Stocks to Pick Up for Less Than $1 appeared first on InvestorPlace.

6 of the Hottest Stocks to Pick Up for Less Than $1

Investors need to pay close attention to Surgalign (SRGA) stock based on the movements in the options market lately.

Are Options Traders Betting on a Big Move in Surgalign (SRGA) Stock?

DEERFIELD, Ill., Sept. 23, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that the Company's Chief Financial and Operating Officer, Jonathon M. Singer, has resigned from the Company, effective October 15, 2021, to pursue another opportunity. Mr. Singer's resignation did not result from any disagreement with the Company. The Company is conducting a search for Mr. Singer's successor.

Surgalign Holdings Announces Management Changes

DEERFIELD, Ill., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global medical technology company focused on elevating the standard of care by driving the evolution of digital surgery, today announced that Sheryl Conley will be appointed to the role of non-executive Chair of the Surgalign Board of Directors, effective September 14, 2021.

Surgalign Appoints Sheryl Conley as Chair of the Board of Directors

Ceragon Networks

Flexion Therapeutics

Hive Blockchain Technologies Ltd

CarLotz

Seanergy Maritime Hlds

trivago

These penny stocks have multiple growth drivers powering their businesses. That will push their prices to record heights in the future.

7 Penny Stocks with Millionaire-Maker Potential

Investors need to pay close attention to Surgalign Holdings (SRGA) stock based on the movements in the options market lately.

Do Options Traders Know Something About Surgalign Holdings (SRGA) Stock We Don't?

The machine learning system is part of HOLO AI™, Surgalign's core technology in artificial intelligence and augmented reality The machine learning system is part of HOLO AI™, Surgalign's core technology in artificial intelligence and augmented reality

Surgalign Announces Issuance of U.S. Patent Covering the Use of Artificial Intelligence in Medical Image Segmentation

Surgalign Holdings (SRGA) stock is on the move Monday following news of the company's CEO buying up shares of SRGA last week. The post SRGA Stock: The CEO Move That Has Surgalign Holdings Surging Today appeared first on InvestorPlace.

SRGA Stock: The CEO Move That Has Surgalign Holdings Surging Today

MannKind

Qumu Corp.

Insiders are buying these penny stocks right now. Should you?

8 Best Penny Stocks To Buy Right Now According To Insiders

The shares of Surgalign Holdings Inc (NASDAQ: SRGA) increased by over 24% pre-market. This is why it happened.

Surgalign Shares Increase Over 20% Pre-Market: Why It Happened

SRGA (a medical device company in spine and digital surgery) is trading like an underfollowed penny-stock at an incredible P/S of 0.55 versus competitors' with P/S profiles of ~3.0.

News for Surgalign Holdings, Inc. Stock (SRGA)